Shares of Maximus, Inc. (NYSE:MMS) have received a consensus recommendation of “Hold” from the eleven research firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating and nine have given a hold rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $61.00.

A number of equities research analysts recently issued reports on the company. Zacks Investment Research lowered Maximus from a “buy” rating to a “hold” rating in a research note on Tuesday, October 10th. Robert W. Baird assumed coverage on Maximus in a research report on Sunday, September 3rd. They set a “neutral” rating for the company. Maxim Group set a $66.00 target price on Maximus and gave the company a “hold” rating in a research report on Thursday, August 3rd. Finally, BidaskClub lowered Maximus from a “hold” rating to a “sell” rating in a research report on Monday, July 24th.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.76 by $0.03. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The firm had revenue of $600.40 million during the quarter, compared to analyst estimates of $614.12 million. During the same period last year, the company earned $0.79 EPS. Maximus’s quarterly revenue was down 2.7% compared to the same quarter last year.

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 30th. Shareholders of record on Wednesday, November 15th will be given a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a yield of 0.27%. The ex-dividend date of this dividend is Tuesday, November 14th. Maximus’s dividend payout ratio (DPR) is presently 5.73%.

In other news, General Counsel David Francis sold 2,000 shares of the business’s stock in a transaction on Friday, August 18th. The stock was sold at an average price of $58.89, for a total value of $117,780.00. Following the completion of the transaction, the general counsel now directly owns 13,716 shares of the company’s stock, valued at approximately $807,735.24. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, President Bruce Caswell sold 8,000 shares of the business’s stock in a transaction on Thursday, August 10th. The stock was sold at an average price of $59.83, for a total value of $478,640.00. Following the completion of the transaction, the president now directly owns 35,904 shares of the company’s stock, valued at $2,148,136.32. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 143,403 shares of company stock valued at $8,866,281. 3.10% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. grew its stake in Maximus by 2.4% during the 2nd quarter. Vanguard Group Inc. now owns 5,669,026 shares of the health services provider’s stock worth $355,052,000 after buying an additional 130,839 shares during the last quarter. FMR LLC grew its stake in Maximus by 10.4% during the 2nd quarter. FMR LLC now owns 4,658,584 shares of the health services provider’s stock worth $291,767,000 after buying an additional 438,025 shares during the last quarter. Victory Capital Management Inc. grew its stake in Maximus by 13.3% during the 3rd quarter. Victory Capital Management Inc. now owns 3,514,228 shares of the health services provider’s stock worth $226,667,000 after buying an additional 413,325 shares during the last quarter. Janus Henderson Group PLC grew its stake in Maximus by 718.8% during the 2nd quarter. Janus Henderson Group PLC now owns 2,211,638 shares of the health services provider’s stock worth $138,515,000 after buying an additional 1,941,521 shares during the last quarter. Finally, State Street Corp grew its stake in Maximus by 3.5% during the 2nd quarter. State Street Corp now owns 2,138,049 shares of the health services provider’s stock worth $133,906,000 after buying an additional 71,823 shares during the last quarter. Hedge funds and other institutional investors own 96.96% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was first reported by American Banking News and is the property of of American Banking News. If you are viewing this story on another domain, it was illegally copied and reposted in violation of US and international trademark and copyright legislation. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/11/02/maximus-inc-mms-given-consensus-rating-of-hold-by-brokerages.html.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Analyst Recommendations for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.